Cannabinoids are known to be lipid modulators that can act through two endocannabinoid receptors (CB1 and CB2) in both tumor-associated and non-tumor macrophages, dendritic cells (DCs), and leukocytes [46,47]. This evidence concerns the gene CNR2 and neoplasm.